Decreased liver-to-spleen ratio in low-dose computed tomography as a biomarker of fatty liver disease reflects risk for myocardial ischaemia
Open Access
- 4 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 1 (1) , qyad016
Abstract
Aims: A strong association between fatty liver disease (FLD) and coronary artery disease is consistently reported. Our aim was to evaluate whether FLD diagnosed using low-dose non-contrast computed tomography (LDCT), as a by-product of myocardial perfusion imaging (MPI), is associated with myocardial ischaemia or left ventricular function parameters. Methods and results: We analysed 742 patients who had undergone MPI using single photon emission computed tomography (SPECT) and LDCT. A liver-to-spleen ratio (in Hounsfield units) of <1 was defined as FLD. Myocardial ischaemia was defined as a summed difference score (SDS) ≥3. Left ventricular size and systolic function were assessed from the electrocardiogram-gated SPECT. FLD patients were younger (63 vs. 68 years) and had a higher body mass index (34.6 vs. 29.0 kg/m2) and a higher SDS (2.65 vs. 1.63), P < 0.001 for all. Independently of several possible confounding factors including traditional risk factors, patients with FLD had a 1.70-fold risk of ischaemia (95% confidence interval 1.11–2.58, P = 0.014). Left ventricular end-diastolic volume (109 vs. 109 mL) and ejection fraction (61 vs. 61%) were comparable in those with and without FLD (non-significant for both). Conclusions: With the help of LDCT, it is possible to identify FLD, which is associated with an increased risk of myocardial ischaemia. Therefore, evaluation of FLD from LDCT is recommended along with MPI.Keywords
Funding Information
- Kuopio University Hospital
- Finnish Foundation for Cardiovascular Research
This publication has 39 references indexed in Scilit:
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Comparison of Left Ventricular Function Between Patients with Non- Alcoholic Fatty Liver Disease and Healthy IndividualsBiomedical and Pharmacology Journal, 2015
- EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revisionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Dose-reduced CT with model-based iterative reconstruction in evaluations of hepatic steatosis: How low can we go?European Journal of Radiology, 2014
- Extrahepatic complications of nonalcoholic fatty liver diseaseHepatology, 2014
- Left Ventricular Dysfunction in Obese Children and Adolescents With Nonalcoholic Fatty Liver DiseaseHepatology, 2013
- Cardiac structure and function are altered in adults with non-alcoholic fatty liver diseaseJournal of Hepatology, 2013
- Low-dose Unenhanced CT for IV Contrast Bolus Timing:: Is It Reliable to Assess Hepatic Steatosis?Academic Radiology, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging AssessmentJournal of Clinical Gastroenterology, 2006